Form 6-K CHINA LIFE INSURANCE CO For: May 25

Commission File Number 001-31914

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

May 25, 2022

China Life Insurance Company Limited

(Translation of registrant’s name into English)

16 Financial Street

Xicheng District

Beijing 100033, China

Tel: (86-10) 6363-3333

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F:

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934:

Yes  ☐            No  ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ___________

Commission File Number 001-31914

On May 25, 2022, China Life Insurance Company Limited issued an announcement in Chinese, the English translation of which is attached as Exhibit 99.1 hereto.

EXHIBIT LIST

Commission File Number 001-31914

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Commission File Number 001-31914

EXHIBIT 99.1

Announcement on the Resolutions of the Twelfth Meeting of the Seventh Session of the

Board of Directors of China Life Insurance Company Limited

The twelfth meeting (the “Meeting”) of the seventh session of the Board of Directors (the “Board”) of China Life Insurance Company Limited (the “Company”) was held on May 25, 2022 by means of written review and telecommunicating voting. The directors were notified of the Meeting by way of a written notice dated May 19, 2022. All of the Company’s nine directors attended the Meeting. The time, venue of the Meeting and the manner in which the Meeting was convened are in accordance with the Company Law of the People’s Republic of China and the provisions under relevant laws, administrative regulations, departmental rules, Articles of Association of the Company and Rules of Procedures for the Board of Directors of the Company.

The directors who attended the Meeting unanimously passed the following resolutions after sufficient review and discussion:

As an adjustment to working arrangements, Wang Junhui, non-executive director of the Company, shall serve as a member of the Nomination and Remuneration Committee; Yuan Changqing, non-executive director of the Company, shall no long serve as a member of the Nomination and Remuneration Committee. After such adjustment, the Nomination and Remuneration Committee will be comprised of Tangxin and Lam Chi Kuen, independent directors of the Company, and Wang Junhui, non-executive director of the Company. Mr. Tang Xin will serve as the Chairman.

Voting result: 9 for, 0 against, with no abstention

Voting result: 9 for, 0 against, with no abstention

Voting result: 9 for, 0 against, with no abstention

Board of Directors of China Life Insurance Company Limited

May 25, 2022

1